{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2e","columns":[{"gene":"","key":"population-60326dafe8034582f6d2","label":"Muscular dystrophy, limb-girdle, type 2E","mondoId":"MONDO:0011423","onsetQualifier":null,"originColumnKey":"MONDO:0011423/OMIM:604286","originalViews":[{"key":"MONDO:0011423/OMIM:604286","label":"Muscular dystrophy, limb-girdle, type 2E","scopeLabel":"OMIM:604286","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["007a1fd7ac9265816691bbdac81cc1a7a02359d8293e43ca70d6da4563d0e2a2","2830b1e545823e599f01de0526cdddde998e47dc5181b84a596d9e0d48bae434","30c6a753770002327af806b82086e095cec7e845001fd165a2d067a6f4586ffa","480b82417996d7838a4e4cfe6218f0b1bae881944c116e5d4bb85bb83b53af91","61d07b21db8b8ad7ba64b937a63176e2ffc597d8e7671e841ee1444ed9a7f2d4","b49bf29828a287050f480026db7b4771e9bf2551cd3fc23c45bbc14e1ba353b5","db0248da211b780b1de3ee15368bdd2b895895a2962c4f96e57ebf5bf1f3bdc8","e65bfaa0b99d44e4f4b0265419a28b9abdc07eee239d6f43b094ef436dc8d612","f521360f0b8968c8aeb6d7251de66559fc5f5510f718c0061531efb0b2848837","fdc4f49d8340274e3a61f20b1d3dad360f4d6c18a7b2f60181116904c5ba336a"],"recordQualifiers":{},"scopeLabel":"OMIM:604286","sourceIds":["OMIM:604286"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-5d1745da5d156ca62926","label":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","mondoId":"MONDO:0011423","onsetQualifier":null,"originColumnKey":"MONDO:0011423/ORPHA:119","originalViews":[{"key":"MONDO:0011423/ORPHA:119","label":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","scopeLabel":"ORPHA:119","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["02b7f9683a002dd7855c8e797c538421984416352d8e439b5ca1cf8bb255ffad","59be363f063913b1c3e1f7e997f030fcfee8824a39d833af6bc80be05c559b51","7d4c649e4dc247b1464ccd67f47ad31018a57a850634ce324b7b26a3c35fc96a","89b3b8d86a660a9bad3d03735895c742c6c291119343e73bd2db8e0c5f78e657","8bcf6b1ae5a90a627346f867cbcc6d21241660f7588a9c6f8ed9ae235e0e1d5e","91ecfd839a2737fc9d236daeaccce7b714f94f761ef15127322cab674bc86a9a","9e0f939b773719157732db9efa6ba71f7ec220f733fb255d8bf9ab7edb1c5230","bd0100f35a4049010ae30bc70b1cf96c248e421911d1ed050ae4c81e6022fe25","c88152293d4e24f133c6bd0cccf0518993f2af213f70a64615bf1a0ff6f9767d","d605410bb26d33fa653513640456189cb234920d1395865445695404744e5e3c","e662a50fa76a06f80dafaa7a5f3cda953f942e0c34c7b4faaec4dba9287be20f","fdfe9950f6a16db1e88bae8719c419b6c8ee9326fe8bd9599c83cd76f33bb7e2","ffac5b13b7dd1a7ea9527d7b7b28c97444067a1a7b8415bb884ccc87853a4a11"],"recordQualifiers":{},"scopeLabel":"ORPHA:119","sourceIds":["ORPHA:119"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-60326dafe8034582f6d2","population-5d1745da5d156ca62926"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002136","HP:0008981","HP:0003707","HP:0001638","HP:0000750","HP:0001644","HP:0003236"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":23,"sourceGroups":{"omim":7,"orphanet":13,"published":3}},"features":[{"hpoId":"HP:0002136","label":"Broad-based gait","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":true},{"hpoId":"HP:0003707","label":"Calf muscle pseudohypertrophy","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":true},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0003391","label":"Gowers sign","primary":false},{"hpoId":"HP:0003557","label":"Increased variability in muscle fiber diameter","primary":false},{"hpoId":"HP:0003325","label":"Limb-girdle muscle weakness","primary":false},{"hpoId":"HP:0002505","label":"Loss of ambulation","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0002913","label":"Myoglobinuria","primary":false},{"hpoId":"HP:0002058","label":"Myopathic facies","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0008988","label":"Pelvic girdle muscle atrophy","primary":false},{"hpoId":"HP:0003749","label":"Pelvic girdle muscle weakness","primary":false},{"hpoId":"HP:0007126","label":"Proximal amyotrophy","primary":false},{"hpoId":"HP:0003691","label":"Scapular winging","primary":false},{"hpoId":"HP:0003724","label":"Shoulder girdle muscle atrophy","primary":false},{"hpoId":"HP:0002515","label":"Waddling gait","primary":false}],"ledeHtml":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 is a type of muscular dystrophy that affects the muscles in the pelvic and shoulder girdles, particularly the pelvic girdle. It usually starts in childhood or adolescence and causes progressive muscle weakness. The knees are usually the earliest and most affected muscles. In advanced stages, the shoulder girdle is also affected, resulting in scapular winging (shoulder blades protrude in abnormal positions), and the distal muscle groups like those of the hands and feet may also be involved. Other symptoms may include calf hypertrophy (enlarged calf muscles), cardiomyopathy (heart muscle disease), respiratory impairment (difficulty breathing), tendon contractures (stiff joints), scoliosis (curvature of the spine), and exercise-induced myoglobinuria (muscle pain and weakness after exercise).","mondoId":"MONDO:0011423","node":{"canonicalSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2e","comparisons":[{"documentSha256":"3d712cb536024986c1e757f70dc88ceab930ff416ae75942f4fa3a4f4b42db07","key":"legacy-autosomal-recessive-limb-girdle-muscular-dystrophy-type-2e","kind":"legacy","label":"autosomal recessive limb-girdle muscular dystrophy type 2E","memberIds":["MONDO:0011423"],"mondoId":"MONDO:0011423","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autosomal-recessive-limb-girdle-muscular-dystrophy-type-2e.3d712cb536024986c1e757f70dc88ceab930ff416ae75942f4fa3a4f4b42db07.json"},{"documentSha256":"44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659","key":"expanded-limb-girdle-muscular-dystrophy","kind":"expanded","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009181","MONDO:0009675","MONDO:0009676","MONDO:0009677","MONDO:0009681","MONDO:0009683","MONDO:0011028","MONDO:0011170","MONDO:0011423","MONDO:0011787","MONDO:0011968","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012215","MONDO:0012248","MONDO:0012652","MONDO:0012699","MONDO:0013161","MONDO:0013162","MONDO:0013297","MONDO:0013390","MONDO:0013440","MONDO:0014142","MONDO:0014144","MONDO:0014474","MONDO:0014489","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0015151","MONDO:0015152","MONDO:0016971","MONDO:0018098","MONDO:0021018","MONDO:0021569","MONDO:0024530","MONDO:0029133","MONDO:0029135","MONDO:0029136","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-44b063290da75047b19d.44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659.json"},{"documentSha256":"2e0cd97961b23a2f8fc63517e1af63e92abc577b7906603cfe24b62bbd2cb6bb","key":"expanded-sarcoglycanopathy","kind":"expanded","label":"sarcoglycanopathy","memberIds":["MONDO:0009677","MONDO:0011028","MONDO:0011423","MONDO:0011702","MONDO:0011968","MONDO:0016140","MONDO:0016141","MONDO:0016142","MONDO:0016143","MONDO:0016144"],"mondoId":"MONDO:0016140","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-2e0cd97961b23a2f8fc6.2e0cd97961b23a2f8fc63517e1af63e92abc577b7906603cfe24b62bbd2cb6bb.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal recessive limb-girdle muscular dystrophy type 2E","originalSourceId":"ORPHA:119","paragraphs":["Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 is a type of muscular dystrophy that affects the muscles in the pelvic and shoulder girdles, particularly the pelvic girdle. It usually starts in childhood or adolescence and causes progressive muscle weakness. The knees are usually the earliest and most affected muscles. In advanced stages, the shoulder girdle is also affected, resulting in scapular winging (shoulder blades protrude in abnormal positions), and the distal muscle groups like those of the hands and feet may also be involved. Other symptoms may include calf hypertrophy (enlarged calf muscles), cardiomyopathy (heart muscle disease), respiratory impairment (difficulty breathing), tendon contractures (stiff joints), scoliosis (curvature of the spine), and exercise-induced myoglobinuria (muscle pain and weakness after exercise)."],"rawAttribution":"MONDO:0011423","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:42Z","upstream":"PlainLanguagePilotV1-Sep23","url":"https://rarediseases.info.nih.gov/diseases/3851"},"ownColumnKeys":["population-60326dafe8034582f6d2","population-5d1745da5d156ca62926"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive limb-girdle muscular dystrophy","mondoId":"MONDO:0015152","slug":null},{"kind":"parent","label":"qualitative or quantitative defects of beta-sarcoglycan","mondoId":"MONDO:0016142","slug":null},{"kind":"parent","label":"familial dilated cardiomyopathy","mondoId":"MONDO:0016333","slug":"familial-dilated-cardiomyopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"007a1fd7ac9265816691bbdac81cc1a7a02359d8293e43ca70d6da4563d0e2a2","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"02b7f9683a002dd7855c8e797c538421984416352d8e439b5ca1cf8bb255ffad","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2830b1e545823e599f01de0526cdddde998e47dc5181b84a596d9e0d48bae434","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0002505","is_excluded":false,"label":"Loss of ambulation","onset_id":"HP:0003621","reference":"PMID:8968749","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"30c6a753770002327af806b82086e095cec7e845001fd165a2d067a6f4586ffa","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008988","is_excluded":false,"label":"Pelvic girdle muscle atrophy","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"480b82417996d7838a4e4cfe6218f0b1bae881944c116e5d4bb85bb83b53af91","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"59be363f063913b1c3e1f7e997f030fcfee8824a39d833af6bc80be05c559b51","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002136","is_excluded":false,"label":"Broad-based gait","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"61d07b21db8b8ad7ba64b937a63176e2ffc597d8e7671e841ee1444ed9a7f2d4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003325","is_excluded":false,"label":"Limb-girdle muscle weakness","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7d4c649e4dc247b1464ccd67f47ad31018a57a850634ce324b7b26a3c35fc96a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002515","is_excluded":false,"label":"Waddling gait","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"89b3b8d86a660a9bad3d03735895c742c6c291119343e73bd2db8e0c5f78e657","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003391","is_excluded":false,"label":"Gowers sign","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8bcf6b1ae5a90a627346f867cbcc6d21241660f7588a9c6f8ed9ae235e0e1d5e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"91ecfd839a2737fc9d236daeaccce7b714f94f761ef15127322cab674bc86a9a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003749","is_excluded":false,"label":"Pelvic girdle muscle weakness","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9e0f939b773719157732db9efa6ba71f7ec220f733fb255d8bf9ab7edb1c5230","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b49bf29828a287050f480026db7b4771e9bf2551cd3fc23c45bbc14e1ba353b5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:8968749","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"bd0100f35a4049010ae30bc70b1cf96c248e421911d1ed050ae4c81e6022fe25","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c88152293d4e24f133c6bd0cccf0518993f2af213f70a64615bf1a0ff6f9767d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d605410bb26d33fa653513640456189cb234920d1395865445695404744e5e3c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"db0248da211b780b1de3ee15368bdd2b895895a2962c4f96e57ebf5bf1f3bdc8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003724","is_excluded":false,"label":"Shoulder girdle muscle atrophy","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e65bfaa0b99d44e4f4b0265419a28b9abdc07eee239d6f43b094ef436dc8d612","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e662a50fa76a06f80dafaa7a5f3cda953f942e0c34c7b4faaec4dba9287be20f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002913","is_excluded":false,"label":"Myoglobinuria","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f521360f0b8968c8aeb6d7251de66559fc5f5510f718c0061531efb0b2848837","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007126","is_excluded":false,"label":"Proximal amyotrophy","onset_id":null,"reference":"OMIM:604286","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"fdc4f49d8340274e3a61f20b1d3dad360f4d6c18a7b2f60181116904c5ba336a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604286","disease_name":"Muscular dystrophy, limb-girdle, type 2E","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0003707","is_excluded":false,"label":"Calf muscle pseudohypertrophy","onset_id":null,"reference":"PMID:8968749","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fdfe9950f6a16db1e88bae8719c419b6c8ee9326fe8bd9599c83cd76f33bb7e2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003557","is_excluded":false,"label":"Increased variability in muscle fiber diameter","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ffac5b13b7dd1a7ea9527d7b7b28c97444067a1a7b8415bb884ccc87853a4a11","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:119","disease_name":"Beta-sarcoglycan-related limb-girdle muscular dystrophy R4","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002058","is_excluded":false,"label":"Myopathic facies","onset_id":null,"reference":"ORPHA:119","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3851\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011423\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV1-Sep23</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 is a type of muscular dystrophy that affects the muscles in the pelvic and shoulder girdles, particularly the pelvic girdle. It usually starts in childhood or adolescence and causes progressive muscle weakness. The knees are usually the earliest and most affected muscles. In advanced stages, the shoulder girdle is also affected, resulting in scapular winging (shoulder blades protrude in abnormal positions), and the distal muscle groups like those of the hands and feet may also be involved. Other symptoms may include calf hypertrophy (enlarged calf muscles), cardiomyopathy (heart muscle disease), respiratory impairment (difficulty breathing), tendon contractures (stiff joints), scoliosis (curvature of the spine), and exercise-induced myoglobinuria (muscle pain and weakness after exercise).</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3851\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2e","sourceDocuments":[{"name":"GARD: Autosomal recessive limb-girdle muscular dystrophy type 2E","reviewed":null,"source_release":"2026-10-21T17:04:42Z","url":"https://rarediseases.info.nih.gov/diseases/3851"},{"name":"MONDO: autosomal recessive limb-girdle muscular dystrophy type 2E","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011423"}],"sourceNote":"","synonyms":["autosomal recessive limb-girdle muscular dystrophy caused by mutation in SGCB","autosomal recessive limb-girdle muscular dystrophy type 2E","beta-sarcoglycan limb-girdle muscular dystrophy","beta-sarcoglycan-related LGMD R4","beta-sarcoglycan-related limb-girdle muscular dystrophy R4","LGMD due to beta-sarcoglycan deficiency","LGMD type 2E","LGMD2E","LGMDR4","limb-girdle muscular dystrophy due to beta-sarcoglycan deficiency","limb-girdle muscular dystrophy type 2E","muscular dystrophy limb-girdle with beta-sarcoglycan deficiency","muscular dystrophy, limb-girdle, autosomal recessive 4","muscular dystrophy, limb-girdle, type 2E","SGCB autosomal recessive limb-girdle muscular dystrophy"],"takeawayHtml":"","title":"autosomal recessive limb-girdle muscular dystrophy type 2E"},"schemaVersion":1}
